To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil

Clinical trial NCT06465264 · COMPLETED

Trial details

NCT number: NCT06465264
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2021-04-29
Primary completion: 2022-08-16
Enrollment: 499

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.